Skip to content Skip to footer

Atopic Dermatitis Clinical Trials

Exploring Potential Treatment Options for Atopic Dermatitis (Eczema)

Is Eczema Affecting Your Daily Life?

Atopic Dermatitis Clinical Trials May Be an Option!

Atopic Dermatitis (AD), the most common form of eczema, is a chronic, inflammatory skin condition that causes the skin to become extremely itchy, red, dry, and cracked. It can affect people of all ages, though it is more common in children. The condition may come and go over time, with periodic flare-ups triggered by environmental allergens, stress, irritants, or infections. AD is often linked to other allergic conditions, such as asthma and hay fever, and is thought to result from a combination of genetic, immune system, and environmental factors.

According to the National Eczema Association, approximately 16.5 million people in the United States have atopic dermatitis. In individuals with AD, the skin’s protective barrier is weakened, leading to increased sensitivity and vulnerability to irritants and allergens. This disruption often results in chronic inflammation, physical discomfort, and emotional distress.

If you or someone you know has Atopic Dermatitis, Revival Research Institute is conducting Atopic Dermatitis Clinical Trials, exploring potential new treatment options.

Are You Eligible to Participate?

To qualify for the Atopic Dermatitis Clinical Trials, participants must:

*Additional criteria may apply.

Participation in the Atopic Dermatitis Clinical Trials is free of cost. To learn more or enroll, fill out the form. A member of our research team will contact you to discuss your potential eligibility for the study.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
This is our Privacy Policy.

About Atopic Dermatitis Clinical Trials

Living with Atopic Dermatitis (AD) can significantly impact your daily life. The relentless itching, skin irritation, and discomfort can disrupt sleep, lower self-esteem, and make everyday routines more difficult.

Revival Research Institute is conducting a clinical trial for individuals with moderate to severe Atopic Dermatitis. This study is designed to evaluate the safety and efficacy of an investigational treatment that may help improve symptoms such as inflammation, itching, and flare-ups.

Clinical trials will be conducted at multiple locations across the United States, including Michigan and Georgia. To qualify, participants must complete a screening process and comply with all study procedures. Those who meet eligibility criteria and are selected for the study will receive either investigational treatment or a placebo.

*All study-related procedures and treatments—including the study treatments—are provided at no cost. No insurance is required to participate, and eligible participants may receive compensation for time and travel. .

*To take the next step, complete the form above. A member from our research team will contact you to determine if you qualify. A brief discussion about your health and medical history may be required.

Get Started: What to Expect?

If you are living with Atopic Dermatitis, you may qualify for a paid clinical trial exploring new treatment options. After completing the interest form above, a member of our research team will contact you for a brief pre-screening to determine if you meet the initial eligibility criteria.

If you qualify, you’ll be asked to review and sign an Informed Consent Form (ICF), which outlines all study procedures, potential benefits, and possible risks. Once consent is given, you will be invited to one of Revival’s research sites for a screening visit. During this visit, we will review your medical history, conduct physical exams, and perform lab tests to further assess your eligibility. If you meet all study requirements, you will be officially enrolled in the Atopic Dermatitis Clinical Trial.

Our team is committed to ensuring you fully understand your role in the study and what to expect throughout. Please feel free to ask any questions before deciding to participate. Your involvement helps advance future treatment options for Atopic Dermatitis.

Age Icon
Age

18 years or older 

Condition Icon
Condition

 Atopic Dermatitis

Location Icon
Location

Georgia & Michigan

Atopic Dermatitis: A Chronic Skin Struggle

Atopic Dermatitis (AD) is a common chronic skin disorder that causes dry, inflamed, and intensely itchy skin. While it often begins in childhood, it can persist into adulthood or even develop later in life. Symptoms may include redness, thickened skin, cracked or weeping lesions, and persistent itching that can disrupt sleep and affect overall well-being.

Commonly affected areas include the hands and feet, the insides of the elbows, behind the knees, the neck, upper chest, and around the eyes and mouth. This condition is more than just skin-deep—it can impact confidence, mental health, and overall quality of life. Flare-ups may be triggered by allergens, stress, irritants, or changes in weather. While topical medications can offer relief, many individuals struggle to find long-term solutions.

Beyond the physical changes, AGA can have a deep psychological impact. Many individuals report increased self-consciousness, reduced confidence, and emotional stress related to their appearance. Social interactions, professional situations, and even daily routines can be affected by the emotional toll of ongoing hair loss.

Atopic Dermatitis May Be Triggered By

Common Symptoms of Atopic Dermatitis Include

Frequently Asked Questions (FAQs)

Your Guide to Atopic Dermatitis

Got questions about Atopic Dermatitis? You’re not alone.

We’ve compiled answers to some of the most common questions about the condition—what causes it, how it’s treated, and what daily life with eczema can look like. Still can’t find what you’re looking for? Our team is here to help. Call us at (248) 721-9539, and we’ll be happy to assist you.

Atopic Dermatitis (eczema) is a long-term inflammatory skin condition that causes red, itchy, and irritated skin. It often starts in childhood but can affect people of any age.

Atopic Dermatitis is typically managed with a combination of treatments, including topical corticosteroids, moisturizers, antihistamines, and, in more severe cases, immunosuppressants or biologic therapies like dupilumab. While there is no permanent cure, these treatments can help control symptoms and reduce flare-ups.

At Revival Research Institute, we’re conducting eczema clinical trials to explore potential new treatment options that may offer long-term relief for those living with moderate to severe eczema.

No, AD or eczema is not contagious. Though susceptibility to AD can be inherited, it cannot be transmitted from person to person.

There’s no cost to participating in our eczema clinical trials, as we cover all the expenses ourselves, including travel and participation costs.